Tri-Olmetor 40 mg Tablets
by TORRENT PHARMACEUTICALS LTD. · 10 Tablets · Over-the-counter
Price: ₹277.61 (MRP ₹326.60) · In stock
Tri-Olmetor 40 mg Tablets contains Olmesartan 40mg + Amlodipine 5mg + Hydrochlorothiazide 12.5mg, manufactured by TORRENT PHARMACEUTICALS LTD.. Buy genuine Tri-Olmetor 40 mg Tablets online at MedZoneAI with fast, reliable delivery across India.
About Tri-Olmetor 40 mg Tablets
Tri-Olmetor 40 mg Tablets is a tablet from TORRENT PHARMACEUTICALS LTD., available as 10 Tablets. It contains Olmesartan 40mg + Amlodipine 5mg + Hydrochlorothiazide 12.5mg.
Common uses: Controls high blood pressure; reduces risk of heart attack and stroke; combines three medicines for effective blood pressure control.
Take it with water exactly as your doctor has advised, and follow the label or your doctor on whether it should be taken before or after food.
Use it only as advised by your doctor or pharmacist, and read the label before use.
Store it as directed on the pack, away from direct sunlight and moisture, and out of the reach of children.
Where other brands with the same composition (Olmesartan 40mg + Amlodipine 5mg + Hydrochlorothiazide 12.5mg) are available, MedZoneAI shows them on this page so you can compare prices before you buy.
Uses of Tri-Olmetor 40 mg Tablets
- Controls high blood pressure
- Reduces risk of heart attack and stroke
- Combines three medicines for effective blood pressure control
Side effects of Tri-Olmetor 40 mg Tablets
- Dizziness or lightheadedness
- Fatigue
- Headache
- Edema (swelling) in legs or feet
- Increased urination
- Low potassium levels
Precautions for Tri-Olmetor 40 mg Tablets
- Tell doctor if you are pregnant or breastfeeding
- Inform doctor of kidney disease, diabetes, or gout
- Avoid potassium supplements unless prescribed
- Limit salt intake
- Tell doctor about all other medicines
Disclaimer: This information is for general awareness only and is not a substitute for professional medical advice. Always consult a qualified doctor or pharmacist before using any medicine.